Jonathan Helfgott is our Co-Founder and a highly regarded regulatory expert with extensive experience and well-established strong ties to the FDA. He specializes in guiding central nervous system (CNS) drug development by providing strategic regulatory insight and ensuring thorough compliance with all relevant guidelines and standards. His expertise plays a crucial role in accelerating the pathway from innovative research and development to effective patient care, ultimately helping to bring new therapies to those in need more efficiently.